Fixes Book Closure for Dividend & AGM
Kilitch Drugs India Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from August 23, 2011 to August 30, 2011 (both days inclusive) for the purpose of Payment of Dividend & 19th Annual General Meeting (AGM) of the Company to be held on August 30, 2011. Outcome of Board Meeting (Dividend)
Kilitch Drugs India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 25, 2011, inter alia, has:1. Recommended dividend @ 10% [i.e. Re. 1/- per equity share of Rs. 10/- each] on the equity shares of the Company, subject to the approval of the Members at the ensuing 19th Annual General Meeting;2. Accepted the resignation tendered by Mr. Nitin C. Shah from the Directorship of the Company w.e.f. July 25, 2011. Audited Financial Results for Mar 31, 2011
Kilitch Drugs India Ltd has informed BSE about the Audited Financial Results for the period ended March 31, 2011. Disclosures under Reg. 7(1) of SEBI (SAST) Regulations, 1997
Paresh Mehta has submitted the disclosure under Regulation 7(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 1997 to BSE Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Kilitch Drugs India Ltd has submitted the disclosure under Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE: Disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Paresh Mehta has submitted the disclosure under Regulation 13(4) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE Disclosures under Reg. 7(1) of SEBI (SAST) Regulations, 1997
Mukund Mehta has submitted the disclosure under Regulation 7(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 1997 to BSE Disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Mukund Mehta has submitted the disclosure under Regulation 13(4) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE Disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Prataprai K Mehta has submitted the disclosure under Regulation 13(4) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE Disclosures under Reg. 7(3) of SEBI (SAST) Regulations, 1997
Kilitch Drugs India Ltd has submitted the disclosure under Regulation 7(3) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 1997 to BSE: